Skip to main content
SpringerLink
Log in

Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

The potential efficacy of a probiotic-based preventative strategy against intestinal mucositis has yet to be investigated in detail. We evaluated supernatants (SN) from Escherichia coli Nissle 1917 (EcN) and Lactobacillus rhamnosus GG (LGG) for their capacity to prevent 5-fluorouracil (5-FU)-induced damage to intestinal epithelial cells. A 5-day study was performed. IEC-6 cells were treated daily from days 0 to 3, with 1 mL of PBS (untreated control), de Man Rogosa Sharpe (MRS) broth, tryptone soy roth (TSB), LGG SN, or EcN SN. With the exception of the untreated control cells, all groups were treated with 5-FU (5 μM) for 24 h at day 3. Transepithelial electrical resistance (TEER) was determined on days 3, 4, and 5, while activation of caspases 3 and 7 was determined on days 4 and 5 to assess apoptosis. Pretreatment with LGG SN increased TEER (p < 0.05) compared to controls at day 3. 5-FU administration reduced TEER compared to untreated cells on days 4 and 5. Pretreatment with MRS, LGG SN, TSB, and EcN SN partially prevented the decrease in TEER induced by 5-FU on day 4, while EcN SN also improved TEER compared to its TSB vehicle control. These differences were also observed at day 5, along with significant improvements in TEER in cells treated with LGG and EcN SN compared to healthy controls. 5-FU increased caspase activity on days 4 and 5 compared to controls. At day 4, cells pretreated with MRS, TSB, LGG SN, or EcN SN all displayed reduced caspase activity compared to 5-FU controls, while both SN groups had significantly lower caspase activity than their respective vehicle controls. Caspase activity in cells pretreated with MRS, LGG SN, and EcN SN was also reduced at day 5, compared to 5-FU controls. We conclude that pretreatment with selected probiotic SN could prevent or inhibit enterocyte apoptosis and loss of intestinal barrier function induced by 5-FU, potentially forming the basis of a preventative treatment modality for mucositis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bowen JM, Gibson RJ, Cummins AG, Keefe DM (2006) Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Canc 14:713–731

    Article  Google Scholar 

  2. Soares PM, Mota JM, Gomes AS, Oliveira RB, Assreuy AM, Brito GA, Santos AA, Ribeiro RA, Souza MH (2008) Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Canc Chemother Pharmacol 63:91–98

    Article  CAS  Google Scholar 

  3. Daniele B, Secondulfo M, De Vivo R, Pignata S, De Magistris L, Delrio P, Palaia R, Barletta E, Tambaro R, Carratu R (2001) Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 32:228–230

    Article  PubMed  CAS  Google Scholar 

  4. Duncan M, Grant G (2003) Oral and intestinal mucositis—causes and possible treatments. Aliment Pharmacol Ther 18:853–874

    Article  PubMed  CAS  Google Scholar 

  5. Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620–1633

    Article  PubMed  Google Scholar 

  6. Prisciandaro LD, Geier MS, Butler RN, Cummins AG, Howarth GS (2011) Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats. Canc Biol Ther 11(7):671–677

    Article  CAS  Google Scholar 

  7. Khailova L, Mount Patrick SK, Arganbright KM, Halpern MD, Kinouchi T, Dvorak B (2010) Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 299:G1118–G1127

    Article  PubMed  CAS  Google Scholar 

  8. Philippe D, Favre L, Foata F, Adolfsson O, Perruisseau-Carrier G, Vidal K, Reuteler G, Dayer-Schneider J, Mueller C, Blum S (2011) Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis. World J Gastroenterol 17:459–469

    Article  PubMed  Google Scholar 

  9. Ueno N, Fujiya M, Segawa S, Nata T, Moriichi K, Tanabe H, Mizukami Y, Kobayashi N, Ito K, Kohgo Y (2011) Heat-killed body of Lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. Inflamm Bowel Dis

  10. Prisciandaro L, Geier M, Butler R, Cummins A, Howarth G (2009) Probiotics and their derivatives as treatments for inflammatory bowel disease. Inflamm Bowel Dis 15(12):1906–1914

    Article  PubMed  Google Scholar 

  11. Seth A, Yan F, Polk DB, Rao RK (2008) Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 294:G1060–G1069

    Article  PubMed  CAS  Google Scholar 

  12. Sokol H, Pigneur B, Watterlot L et al (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105:16731–16736

    Article  PubMed  CAS  Google Scholar 

  13. Donato KA, Gareau MG, Wang YJ, Sherman PM (2010) Lactobacillus rhamnosus GG attenuates interferon-γ and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling. Microbiology 156:3288–3297

    Article  PubMed  CAS  Google Scholar 

  14. Lin PW, Nasr TR, Berardinelli AJ, Kumar A, Neish AS (2008) The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut. Pediatr Res 64:511–516

    Article  PubMed  Google Scholar 

  15. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W, Bleich A, Bruder D, Franzke A, Rogler G, Suerbaum S, Buer J, Gunzer F, Westendorf AM (2007) Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2:e1308

    Article  PubMed  Google Scholar 

  16. Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33:448–460

    Article  PubMed  CAS  Google Scholar 

  17. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA (2007) Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 9:804–816

    Article  PubMed  CAS  Google Scholar 

  18. Basuroy S, Sheth P, Kuppuswamy D, Balasubramanian S, Ray RM, Rao RK (2003) Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem 278:11916–11924

    Article  PubMed  CAS  Google Scholar 

  19. Otte JM, Mahjurian-Namari R, Brand S, Werner I, Schmidt WE, Schmitz F (2009) Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr Cancer 61:103–113

    Article  PubMed  CAS  Google Scholar 

  20. Johnson-Henry KC, Donato KA, Shen-Tu G, Gordanpour M, Sherman PM (2008) Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun 76:1340–1348

    Article  PubMed  CAS  Google Scholar 

  21. Myllyluoma E, Ahonen AM, Korpela R, Vapaatalo H, Kankuri E (2008) Effects of multispecies probiotic combination on Helicobacter pylori infection in vitro. Clin Vaccine Immunol 15:1472–1482

    Article  PubMed  CAS  Google Scholar 

  22. Sanchez B, Schmitter JM, Urdaci MC (2009) Identification of novel proteins secreted by Lactobacillus rhamnosus GG grown in de Mann-Rogosa-Sharpe broth. Lett Appl Microbiol 48:618–622

    Article  PubMed  CAS  Google Scholar 

  23. Lin YP, Thibodeaux CH, Pena JA, Ferry GD, Versalovic J (2008) Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis 14:1068–1083

    Article  PubMed  Google Scholar 

  24. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132:562–575

    Article  PubMed  CAS  Google Scholar 

  25. Oxoid (2010) Dehydrated culture media: modified tryptone soya broth. [Online]. Available at http://www.oxoid.com/UK/blue/prod_detail/prod_detail.asp?pr=CM0989&sec=2&org=72&c=UK&lang=EN (accessed on February 1st 2011)

  26. Tuhacek LM, Mackey AD, Li N, DeMarco VG, Stevens G, Neu J (2004) Substitutes for glutamine in proliferation of rat intestinal epithelial cells. Nutrition 20:292–297

    Article  PubMed  CAS  Google Scholar 

  27. Li N, Neu J (2009) Glutamine deprivation alters intestinal tight junctions via a PI3-K/Akt mediated pathway in Caco-2 cells. J Nutr 139:710–714

    Article  PubMed  CAS  Google Scholar 

  28. Potsic B, Holliday N, Lewis P, Samuelson D, DeMarco V, Neu J (2002) Glutamine supplementation and deprivation: effect on artificially reared rat small intestinal morphology. Pediatr Res 52:430–436

    Article  PubMed  CAS  Google Scholar 

  29. Sukhotnik I, Mogilner JG, Karry R, Shamian B, Lurie M, Kokhanovsky N, Ure BM, Coran AG (2009) Effect of oral glutamine on enterocyte turnover during methotrexate-induced mucositis in rats. Digestion 79:5–13

    Article  PubMed  CAS  Google Scholar 

  30. Windmueller HG, Spaeth AE (1974) Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 249:5070–5079

    PubMed  CAS  Google Scholar 

  31. Oxoid (2010) Dehydrated culture media: MRS broth (De Man, Rogosa, Sharpe). [Online]. Available at http://www.oxoid.com/UK/blue/prod_detail/prod_detail.asp?pr=CM0359&c=UK&lang=EN (accessed on February 1st 2011)

  32. Yu LC, Flynn AN, Turner JR, Buret AG (2005) SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J 19:1822–1835

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

I, Luca Prisciandaro, state that there is no conflict of interest associated with this manuscript. I declare that the current work was not financially sponsored by any organization. The authorship of this manuscript is as described in the attached Authorship/Disclosure form, with myself as the first author. I have a full control of all primary data related to this manuscript and would be happy to allow the journal to review this data if necessary.

Author information

Authors and Affiliations

  1. School of Animal and Veterinary Sciences, University of Adelaide (Roseworthy Campus), Roseworthy, South Australia, Australia

    Luca D. Prisciandaro, Mark S. Geier, Ross N. Butler & Gordon S. Howarth

  2. Centre for Pediatric and Adolescent Gastroenterology, Women’s and Children’s Hospital, 72 King William Road, North Adelaide, South Australia, Australia

    Luca D. Prisciandaro & Gordon S. Howarth

  3. Department of Gastroenterology and Hepatology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia

    Luca D. Prisciandaro, Adrian G. Cummins & Guy R. Sander

  4. South Australian Research and Development Institute, Adelaide, South Australia, Australia

    Mark S. Geier

  5. Discipline of Physiology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia

    Ann E. Chua

  6. Pediatric Education and Research Institute, Sansom Institute, University of South Australia, Adelaide, South Australia, Australia

    Ross N. Butler

Authors
  1. Luca D. Prisciandaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark S. Geier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ann E. Chua
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ross N. Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adrian G. Cummins
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guy R. Sander
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gordon S. Howarth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luca D. Prisciandaro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prisciandaro, L.D., Geier, M.S., Chua, A.E. et al. Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage. Support Care Cancer 20, 3205–3210 (2012). https://doi.org/10.1007/s00520-012-1446-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-012-1446-3

Keywords

Search

Navigation